Becton, Dickinson and Company (BD) has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush prefilled flush syringes at its facility in Columbus, Nebraska, US. This ...

BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

New Manufacturing Lines Will Provide U.S. Government with Priority Access to Hundreds of Millions of Needles and Syringes; Bolster Supply Readiness FRANKLIN LAKES, N.J., Oct. 7, 2021 /PRNewswire/ -- ...

FRANKLIN LAKES, N.J., Dec. 2, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 ...

The Syringes and Injection Needle Manufacturing industry has experienced steady growth in the five years to 2014, mainly due to favorable demographic shifts, increased health insurance coverage and ...

FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...

West has launched Synchrony S1, a prefillable syringe system to simplify biologic delivery and combination product needs.

THE Senate has urged the Federal Government to come forward with a policy that will ensure that all government funded hospitals in the country procure their syringes and needles from local ...